2 Magnificent Stocks to Buy That Are Near Their 52-Week Lows
Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that ...
TD Cowen Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...
TD Cowen Remains a Buy on Springworks Therapeutics (SWTX)
TD Cowen analyst Yaron Werber maintained a Buy rating on Springworks Therapeutics (SWTX – Research Report) today and set a price target of ...
Global Pharma & Biotech CRM Software Market To Surpass Valuation Of US$ 20.0 Billion By 2033 | Astute Analytica
New Delhi, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The global pharma & biotech CRM software market was valued at US$ 7.21 billion IN 2024 and is projected to reach US$ 20.0 by 2033 at a CAGR of 15.2% during ...
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
A $5,000 investment can go a long way, especially if you're loading up on fairly cheap stocks that may possess a lot of ...
MM&M3d
These CEOs want to market the next Ozempic. Just don’t call it that
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
JD Supra5d
Year in Review: Top Regulatory Developments of 2024
As 2025 begins, we would like to reflect on last year’s regulatory developments in the biologics and biosimilars space. Here are ...
AOL5d
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
Pharmaceutical company Amgen is another example of a business ... ranging from consumer products to electronics to home goods to plastics, and many others. Prologis' top 10 customers only account ...